[go: up one dir, main page]

AU2826099A - Heterocyclic compounds regulating clotting - Google Patents

Heterocyclic compounds regulating clotting

Info

Publication number
AU2826099A
AU2826099A AU28260/99A AU2826099A AU2826099A AU 2826099 A AU2826099 A AU 2826099A AU 28260/99 A AU28260/99 A AU 28260/99A AU 2826099 A AU2826099 A AU 2826099A AU 2826099 A AU2826099 A AU 2826099A
Authority
AU
Australia
Prior art keywords
heterocyclic compounds
compounds regulating
clotting
regulating clotting
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28260/99A
Inventor
Palle Jakobsen
Egon Persson
Helle Worsaae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2826099A publication Critical patent/AU2826099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU28260/99A 1998-03-24 1999-03-17 Heterocyclic compounds regulating clotting Abandoned AU2826099A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DK41398 1998-03-24
DK413/98 1998-03-24
DK464/98 1998-04-02
DK46498 1998-04-02
DKPA 1998-10-02
DKPA199801559 1998-11-26
PCT/DK1999/000138 WO1999048878A1 (en) 1998-03-24 1999-03-17 Heterocyclic compounds regulating clotting

Publications (1)

Publication Number Publication Date
AU2826099A true AU2826099A (en) 1999-10-18

Family

ID=27220664

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28260/99A Abandoned AU2826099A (en) 1998-03-24 1999-03-17 Heterocyclic compounds regulating clotting

Country Status (2)

Country Link
AU (1) AU2826099A (en)
WO (1) WO1999048878A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL133625A0 (en) 1997-06-26 2001-04-30 Lilly Co Eli Antithrombotic agents
ES2241151T3 (en) 1997-06-26 2005-10-16 Eli Lilly And Company ANTITROMBOTIC AGENTS.
AU8270898A (en) 1997-06-26 1999-01-19 Eli Lilly And Company Antithrombotic agents
WO2000030646A1 (en) * 1998-11-26 2000-06-02 Novo Nordisk A/S Heterocyclic compounds regulating clotting
JP2003512423A (en) 1999-10-27 2003-04-02 スノル・モレキュラー・コーポレーション Tissue factor antagonists and methods of use
EP1829535A3 (en) * 1999-10-27 2007-10-24 Tanox, Inc. Tissue factor antagonists and methods of use thereof
AU2002317377A1 (en) * 2001-07-20 2003-03-03 Cancer Research Technology Limited Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
WO2003016292A1 (en) * 2001-08-13 2003-02-27 Ciba Specialty Chemicals Holding Inc. Ultraviolet light absorbers
US6774232B2 (en) * 2001-10-22 2004-08-10 Cytec Technology Corp. Low color, low sodium benzoxazinone UV absorbers and process for making same
EP1644369A2 (en) 2003-07-02 2006-04-12 F. Hoffmann-La Roche Ag Arylamine-substituted quinazolinone compounds
TWI419884B (en) * 2010-06-24 2013-12-21 Univ Chang Gung Benzoxazinone derivatives, their preparation processes, and pharmaceutical compositions comprising the same
LT3097085T (en) 2014-01-23 2020-10-12 Sixera Pharma Ab Benzoxazinone derivatives for treatment of skin diseases
WO2022253911A1 (en) * 2021-06-01 2022-12-08 Sixera Pharma Ab Oil-in-water emulsion of 6-ethoxy-7-methoxy-2-(2-methylsulfanylphenyl)-3,l-benzoxazin-4-one

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210669A (en) * 1983-12-27 1988-05-30 Syntex Inc Benzoxazin-4-one derivatives and pharmaceutical compositions
US4665070A (en) * 1985-06-25 1987-05-12 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and pharmaceutical use
US5652237A (en) * 1994-09-09 1997-07-29 Warner-Lambert Company 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes

Also Published As

Publication number Publication date
WO1999048878A1 (en) 1999-09-30

Similar Documents

Publication Publication Date Title
AU1978699A (en) Heterocyclic compounds
AU4580599A (en) Stable no-delivering compounds
AU2863899A (en) New compounds
AUPP003197A0 (en) New heterocyclic compounds
AU4260199A (en) Novel compounds
AU7907498A (en) Novel heterocyclic compounds
AU1424200A (en) Compounds
AU4501699A (en) Aminoazole compounds
AU7907298A (en) Novel heterocyclic compounds
AU5980899A (en) Novel compounds
AU2739899A (en) Well control
AU2014800A (en) Novel compounds
AU2826099A (en) Heterocyclic compounds regulating clotting
AU1434500A (en) Compounds
AU6291098A (en) Novel heterocyclic compounds
AU4814699A (en) Novel compounds
AU6059999A (en) 2-substituted heterocyclic sulfonamides
AU4167099A (en) Heterocyclic compounds as hypoglycemic agents
AU1375000A (en) Heterocyclic compounds regulating clotting
AUPO622597A0 (en) New heterocyclic compounds
AU2187799A (en) Novel taxaneterpine compounds
AUPO527597A0 (en) Novel heterocyclic compounds
AU1682400A (en) 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
AU3730699A (en) Heterocyclic compound
AU1983599A (en) Oxygenic heterocyclic compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase